Call to make an appointment.
Norton Cancer Institute is the leading provider of care for Hodgkin lymphoma and non-Hodgkin lymphoma in Louisville and Southern Indiana. We provide a comprehensive range of treatments for lymphoma.
Our lymphoma specialists are board-certified and fellowship-trained leaders in their field. They’re at the forefront of developing innovative approaches to getting patients back to living their lives.
If you’ve been diagnosed with lymphoma, you want to start getting better right away. That’s why we offer same-day appointments for newly diagnosed patients.
At Norton Cancer Institute, you’ll have a one-on-one relationship with your oncologist, surgeon, radiation oncologist or other specialist. The next cancer doctor you see will be either someone you know or someone you’ll be seeing again who knows your case.
Lymphoma is a cancer that starts in the lymphocytes, a type of white blood cell. If not treated, it can spread throughout the lymph system and eventually to other parts of the body.
There are two main types of lymphoma:Hodgkin lymphoma, also called Hodgkin disease, and non-Hodgkin lymphoma. Different types of lymphoma spread in different ways and require different treatments.
Our team of doctors have been at the forefront of discovery in the treatment of lymphomas.
We use the latest equipment and procedures to make a precise diagnosis that shows the stage of your cancer. We use that, along with information about any other medical conditions you have, to tailor a treatment plan just for you.
You’ll also have access to innovative clinical trials, lymphoma support services and a dedicated patient navigator to walk you through every phase of care.
Our state-of-the-art treatments include immunotherapy and biologic therapies that can provide a unique treatment designed specifically to combat the genetic makeup of your cancer.
We often treat Hodgkin lymphoma with radiation and chemotherapy. We sometimes use radiation and/or chemotherapy to treat non-Hodgkin lymphoma. Depending on your condition, our specialists also might use monoclonal antibody therapy as well as radio immunotherapy.
The U.S. Food and Drug Administration recently approved a drug, Aliqopa, to treat follicular lymphoma after a trial co-led by Don A. Stevens, M.D., director of the Hematologic Malignancy Program at Norton Cancer Institute. Dr. Stevens and one other researcher nationwide were responsible for enrolling patients in clinical trials that led to Aliqopa getting federal approval.
Patients can participate in innovative National Cancer Institute- and industry-sponsored clinical research studies. These trials help improve current cancer treatments, in addition to finding new and promising solutions.